← Leaderboards
Yang-Xin Fu
University Of Chicago
$17,180,976
Attributed
$18,226,298
Total exposure
14
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–18$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$18,226,298 · 14
By mechanism
R01$16,140,815 · 9
P01$1,351,907 · 1
R21$426,660 · 1
K08$237,762 · 1
R03$67,701 · 1
P41$1,453 · 1
Top collaborators
- Lishan Su5 shared
Most similar at University Of Chicago
Same institution · by research overlap
- Thomas F Gajewski$23,743,716
- Barbara Lynne Kee$17,058,338
- Bana Jabri$21,767,484
- Richard P Kraig$8,672,499
- Kunle O Odunsi$16,178,755
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingSignal TransductionT-LymphocyteImmunityImmuneResponseImmune ResponseTumor Necrosis Factor-BetaImmunotherapyPathway InteractionsTissuesCellsLymph NodesTumorNovel StrategiesNeoplasm MetastasisAntigensReceptorPreventAntibodiesLeadLymphoidRecruitment ActivityRegulation
Grant awards (63)
Synergy of Radiation and Immunotherapy: New Approaches$384,750
R01 · FY2018 · CA · contact PI
Synergy of Radiation and Immunotherapy: New Approaches$384,750
R01 · FY2017 · CA · contact PI
The role of Id2 in gut innate lymphoid cells$352,350
R01 · FY2017 · DK · contact PI
Novel therapeutic approaches to treating chronic hepatitis B virus infection$486,852
R01 · FY2016 · DK
Synergy of Radiation and Immunotherapy: New Approaches$384,156
R01 · FY2016 · CA · contact PI
The role of Id2 in gut innate lymphoid cells$352,079
R01 · FY2016 · DK · contact PI
Novel therapeutic approaches to treating chronic hepatitis B virus infection$551,970
R01 · FY2015 · DK
Synergy of Radiation and Immunotherapy: New Approaches$369,960
R01 · FY2015 · CA · contact PI
The role of Id2 in gut innate lymphoid cells$338,806
R01 · FY2015 · DK · contact PI
Novel therapeutic approaches to treating chronic hepatitis B virus infection$486,852
R01 · FY2014 · DK
The role of Id2 in gut innate lymphoid cells$338,806
R01 · FY2014 · DK · contact PI
Synergy of radiation and immunotherapy: new approaches$322,083
R01 · FY2014 · CA · contact PI
TNF family members for lymph angiogenesis and lymph node hypertrophy$304,570
R01 · FY2014 · CA · contact PI
Novel therapeutic approaches to treating chronic hepatitis B virus infection$65,118
R01 · FY2014 · DK
Novel therapeutic approaches to treating chronic hepatitis B virus infection$499,852
R01 · FY2013 · DK
Synergy of radiation and immunotherapy: new approaches$332,044
R01 · FY2013 · CA · contact PI
TNF family members for lymph angiogenesis and lymph node hypertrophy$295,150
R01 · FY2013 · CA · contact PI
Synergy of radiation and immunotherapy: new approaches$353,238
R01 · FY2012 · CA · contact PI
TNF family members for lymph angiogenesis and lymph node hypertrophy$313,989
R01 · FY2012 · CA · contact PI
LIGHT for the Recognition and Eradication of Advanced Cancer$264,778
P01 · FY2012 · CA · contact PI
Synergy of radiation and immunotherapy: new approaches$353,238
R01 · FY2011 · CA · contact PI
TNF family members for lymph angiogenesis and lymph node hypertrophy$313,989
R01 · FY2011 · CA · contact PI
LIGHT for the Recognition and Eradication of Advanced Cancer$263,760
P01 · FY2011 · CA · contact PI
The Role of Negative Signal in Early Infection$231,660
R21 · FY2011 · AI · contact PI
TNF family members for lymph angiogenesis and lymph node hypertrophy$323,700
R01 · FY2010 · CA · contact PI
LIGHT for the Recognition and Eradication of Advanced Cancer$273,414
P01 · FY2010 · CA · contact PI
Enhanced Immunity Inside of Tumor Microenvironment$264,562
R01 · FY2010 · CA · contact PI
The Role of Negative Signal in Early Infection$195,000
R21 · FY2010 · AI · contact PI
Synergy of radiation and immunotherapy: new approaches$161,850
R01 · FY2010 · CA · contact PI
Enhanced Immunity Inside of Tumor Microenvironment$383,381
R01 · FY2009 · CA · contact PI
The Role of Lymphoid Microenvironment in Autoimmunity$333,010
R01 · FY2009 · DK · contact PI
LIGHT for the Recognition and Eradication of Advanced Cancer$270,419
P01 · FY2009 · CA · contact PI
Development and Function of Lymphoid Tissues$349,937
R01 · FY2008 · AI · contact PI
The Role of Lymphoid Microenvironment in Autoimmunity$333,010
R01 · FY2008 · DK · contact PI
LIGHT for the Recognition and Eradication of Advanced Cancer$279,536
P01 · FY2008 · CA · contact PI
Enhanced Immunity Inside of Tumor Microenvironment$264,562
R01 · FY2008 · CA · contact PI
Enhanced Immunity Inside of Tumor Microenvironment$132,028
R01 · FY2008 · CA · contact PI
The Role of IgE in Airway Inflammation$356,715
R01 · FY2007 · HL · contact PI
Development and Function of Lymphoid Tissues$356,715
R01 · FY2007 · AI · contact PI
The Role of Lymphoid Microenvironment in Autoimmunity$339,805
R01 · FY2007 · DK · contact PI
Enhanced Immunity Inside of Tumor Microenvironment$264,562
R01 · FY2007 · CA · contact PI
The Role of IgE in Airway Inflammation$367,369
R01 · FY2006 · HL · contact PI
Development and Function of Lymphoid Tissues$367,369
R01 · FY2006 · AI · contact PI
The Role of Lymphoid Microenvironment in Autoimmunity$349,954
R01 · FY2006 · DK · contact PI
Enhanced Immunity Inside of Tumor Microenvironment$272,019
R01 · FY2006 · CA · contact PI
The Role of IgE in Airway Inflammation$376,210
R01 · FY2005 · HL
Development and Function of Lymphoid Tissues$376,210
R01 · FY2005 · AI
The Role of Lymphoid Microenvironment in Autoimmunity$358,375
R01 · FY2005 · DK
GENERATION OF SULFENAMIDES, SULFINAMIDES, &SULFONAMIDES BY HYPOCHLOROUS ACID$649
P41 · FY2005 · RR
The Role of IgE in Airway Inflammation$376,210
R01 · FY2004 · HL
THE ROLE OF LYMPHOID MICROENVIRONMENT IN AUTOIMMUNITY$290,290
R01 · FY2004 · DK
Development and Function of Lymphoid Tissues$190,625
R01 · FY2004 · AI
GENERATION OF SULFENAMIDES, SULFINAMIDES, &SULFONAMIDES BY HYPOCHLOROUS ACID$804
P41 · FY2004 · RR
THE ROLE OF LYMPHOID MICROENVIRONMENT IN AUTOIMMUNITY$291,236
R01 · FY2003 · DK
DEVELOPMENT AND FUNCTION OF LYMPHOID TISSUES$147,894
R01 · FY2003 · HD
THE ROLE OF LYMPHOID MICROENVIRONMENT IN AUTOIMMUNITY$292,154
R01 · FY2002 · DK
DEVELOPMENT AND FUNCTION OF LYMPHOID TISSUES$144,899
R01 · FY2002 · HD
THE ROLE OF LYMPHOID MICROENVIRONMENT IN AUTOIMMUNITY$293,045
R01 · FY2001 · DK
LYMPHOTOXIN ALPHA IN SYSTEMIC IMMUNE RESPONSE$118,881
K08 · FY2001 · AI
DEVELOPMENT AND FUNCTION OF LYMPHOID TISSUES$99,832
R01 · FY2001 · HD
LYMPHOTOXIN ALPHA IN SYSTEMIC IMMUNE RESPONSE$118,881
K08 · FY2000 · AI
DEVELOPMENT AND FUNCTION OF LYMPHOID TISSUES$98,685
R01 · FY2000 · HD
DEVELOPMENT OF NK CELLS BY LYMPHOTOXIN$67,701
R03 · FY2000 · HD